Drawing for VLIP

USPTO serial 76159506

VLIP

Reviewed by CopyMark Law Group

Reg. 2665353Status 710
Filing date
Status date
Registration date
Dec 24, 2002
Examiner
BUSH, KAREN K
Law office
—

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with VLIP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

Lawrence E. Abelman ABELMAN FRAYNE & SCHWAB666 THIRD AVENUENEW YORK, NY 10017-5621UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001[ Assay reagents for biotechnological and chemical research; chemical additives for the storage of biologically and/or pharmacologically active substances; chemicals used in the form of vesicles or virus-like particles; vesicles or virus-like particles for the storage of biological and/or synthetic material, namely peptides, proteins, nucleic acids, antibodies, antigens, nucleotides, or oligonucleotides; chemicals used in the analysis of substances for their biological and/or pharmaceutical activity; photographic chemicals; kits comprising chemical additives, namely buffer reagents, and vesicles and/or virus-like particles ]SECTION 8 - CANCELLED—
005[ Pharmaceutical and veterinary-medical preparations for the purpose of delivery of biologically and/or pharmacologically active substances or screening for biologically and/or pharmacologically active substances; diagnostic reagents; assay reagents for medical diagnoses and use in the development of pharmaceutical, veterinary and sanitary preparations which are used for delivery of biologically and/or pharmacologically active substances or screening for biologically and/or pharmacologically active substances ]SECTION 8 - CANCELLED—
009[ Scientific apparatus and instruments used to analyze, sort, and recover chemical substances, cells, vesicles, virus-like particles and beads; chips, and hybrid chips; lab-on-chip devices, namely three-dimensional microchannel chips, dielectrophoretic field effect chips; dispensing and pipetting devices, namely micropipettes, microdispensers, and micropumps for pipetting and dispensing fluids; micro mounting devices, namely laser tweezers, electrical field cages and electrical barriers; microfluidic systems in the form of microchannels and micro compartments; optical instruments and laboratory equipment, namely microscopes, confocal microscopes, microscope and confocal microscope based detectors, photodiodes, CCD chips, spectroscopes, namely luminometers, fluorometers, all for research and industrial use in the fields of biotechnology, chemistry, medicine, pharmacology and diagnostics; computer software and pre-recorded magnetic data carriers containing computer programs for use in collecting and evaluating data in the fields of biotechnology, chemistry, medicine, pharmacology and diagnostics ]SECTION 8 - CANCELLED—
042Consultation, research and development services in the field of biotechnology, pharmacology, medicine, diagnostics and chemistry, namely in the field of genomics, proteomics or biologically active and/or pharmaceutically active substances; consultation, research and development regarding products and methods in the field of biotechnology, pharmacology, medicine, diagnostics and chemistry, namely in the field of genomics, proteomics or biologically active and/or pharmaceutically active substancesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 26, 2013CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Dec 20, 20088.PRREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED—
Dec 17, 2008PLGLASSIGNED TO PARALEGAL—
Dec 12, 20088.AFREGISTERED - SEC. 8 (6-YR) FILED—
Dec 12, 2008ES8RTEAS SECTION 8 RECEIVED—
Feb 15, 2008CFITCASE FILE IN TICRS—
Sep 23, 2006CORVREVIEW OF CORRESPONDENCE COMPLETE—
Aug 21, 2006MAILPAPER RECEIVED—
Dec 24, 2002R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 1, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 11, 2002NPUBNOTICE OF PUBLICATION—
May 7, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2002NPUBNOTICE OF PUBLICATION—
Jan 16, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 14, 20021.BDSec. 1(B) CLAIM DELETED—
Oct 1, 200144DDSEC. 44(D) CLAIM DELETED—
Oct 1, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 3, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance